{"id":"https://openalex.org/W2015652530","doi":"https://doi.org/10.1093/jac/dkq255","title":"CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections","display_name":"CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections","publication_year":2010,"publication_date":"2010-11-01","ids":{"openalex":"https://openalex.org/W2015652530","doi":"https://doi.org/10.1093/jac/dkq255","mag":"2015652530","pmid":"https://pubmed.ncbi.nlm.nih.gov/21115455"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkq255","doi":"https://doi.org/10.1093/jac/dkq255","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkq255","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027928189","display_name":"Mark H. Wilcox","orcid":"https://orcid.org/0000-0002-4565-2868","observed_orcids":["https://orcid.org/0000-0002-4565-2868"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]},{"id":"https://openalex.org/I2799390153","display_name":"Leeds Teaching Hospitals NHS Trust","ror":"https://ror.org/00v4dac24","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"M. H. Wilcox","raw_affiliation_strings":["Department of Microbiology, Leeds Teaching Hospitals & University of Leeds, Leeds, UK. mark.wilcox@leedsth.nhs.uk","Department of Microbiology, Leeds Teaching Hospitals & University of Leeds, Leeds LS1 3EX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Leeds Teaching Hospitals & University of Leeds, Leeds, UK. mark.wilcox@leedsth.nhs.uk","institution_ids":["https://openalex.org/I130828816","https://openalex.org/I2799390153"]},{"raw_affiliation_string":"Department of Microbiology, Leeds Teaching Hospitals & University of Leeds, Leeds LS1 3EX, UK","institution_ids":["https://openalex.org/I130828816","https://openalex.org/I2799390153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059959498","display_name":"G. Ralph Corey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. R. Corey","raw_affiliation_strings":["Division of Infectious Diseases, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080609948","display_name":"George H. Talbot","orcid":"https://orcid.org/0000-0002-2868-2707","observed_orcids":["https://orcid.org/0000-0002-2868-2707"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. H. Talbot","raw_affiliation_strings":["Talbot Advisors LLC, Wayne, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Talbot Advisors LLC, Wayne, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053400330","display_name":"Dirk A. Thye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273071","display_name":"Cerexa (United States)","ror":"https://ror.org/057xv8209","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273071"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Thye","raw_affiliation_strings":["Cerexa, Inc., Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerexa, Inc., Oakland, CA, USA","institution_ids":["https://openalex.org/I4405273071"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Friedland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273071","display_name":"Cerexa (United States)","ror":"https://ror.org/057xv8209","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273071"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Friedland","raw_affiliation_strings":["Cerexa, Inc., Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerexa, Inc., Oakland, CA, USA","institution_ids":["https://openalex.org/I4405273071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020423749","display_name":"Tanya Baculik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273071","display_name":"Cerexa (United States)","ror":"https://ror.org/057xv8209","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273071"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Baculik","raw_affiliation_strings":["Cerexa, Inc., Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerexa, Inc., Oakland, CA, USA","institution_ids":["https://openalex.org/I4405273071"]}]},{"author_position":"middle","author":{"id":null,"display_name":"on behalf of the CANVAS 2 investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"on behalf of the CANVAS 2 investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108539437","display_name":"Paul Manos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Manos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"P. Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"L. Bush","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Bush","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066108584","display_name":"Jennifer M. DeSanto","orcid":"https://orcid.org/0000-0001-6499-9536","observed_orcids":["https://orcid.org/0000-0001-6499-9536"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. DeSanto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002766172","display_name":"Luis J\u00e1uregui-Peredo","orcid":"https://orcid.org/0000-0002-8623-5999","observed_orcids":["https://orcid.org/0000-0002-8623-5999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Jauregui-Peredo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012545620","display_name":"Thomas G. Sheftel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Sheftel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111673292","display_name":"John R. Pullman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Pullman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110024942","display_name":"C. G. Schrock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Schrock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059773999","display_name":"Harold C. Standiford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Standiford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"R. Mason","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Mason","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097506881","display_name":"J. Guetzkow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Guetzkow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086799169","display_name":"CHRISTOPHER J. LUCASTI","orcid":"https://orcid.org/0000-0001-8720-7677","observed_orcids":["https://orcid.org/0000-0001-8720-7677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Lucasti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091044247","display_name":"Joseph Surber","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Surber","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100666688","display_name":"Steven Lee","orcid":"https://orcid.org/0000-0002-6853-1460","observed_orcids":["https://orcid.org/0000-0002-6853-1460"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070934403","display_name":"Victoria A. Samonte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Samonte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103929030","display_name":"Carmen Grimaldos Rodriguez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. G. Rodriguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103496656","display_name":"Javier D. Altclas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. D. Altclas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109905626","display_name":"Carlos Bergallo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. E. Bergallo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002369396","display_name":"Mar\u00eda Mastruzzo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. A. Mastruzzo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012546212","display_name":"G. I. Morera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. I. Morera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075956101","display_name":"Sergio Prieto","orcid":"https://orcid.org/0000-0002-7242-5265","observed_orcids":["https://orcid.org/0000-0002-7242-5265","https://orcid.org/0000-0002-5708-0828"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. E. Prieto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077054728","display_name":"Christian Remolif","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. G. Remolif","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108389843","display_name":"Anna M. Timmerman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Timmerman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A. Freire","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Freire","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M. Calvo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Calvo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"C. Chain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Chain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031922187","display_name":"Alvaro Llancaqueo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Llancaqueo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023239691","display_name":"G. Amaya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Amaya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053271642","display_name":"Enriqueta Cede\u00f1o Rodr\u00edguez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Rodriguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082013622","display_name":"I. S. Osipov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. S. Osipov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087996027","display_name":"A. V. Konychev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. V. Konychev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082239427","display_name":"Sergei A. Shlyapnikov","orcid":"https://orcid.org/0000-0002-6182-8333","observed_orcids":["https://orcid.org/0000-0002-6182-8333"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. A. Shlyapnikov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025805034","display_name":"Aleksandr M. Shulutko","orcid":"https://orcid.org/0000-0002-8001-1601","observed_orcids":["https://orcid.org/0000-0002-8001-1601"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. M. Shulutko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J. Zuckerman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Zuckerman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"D. Bachter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Bachter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082683957","display_name":"Philipp Kohl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Kohl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080932090","display_name":"Margo L. Schilling","orcid":"https://orcid.org/0000-0001-9684-9866","observed_orcids":["https://orcid.org/0000-0001-9684-9866"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Schilling","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J. Kulig","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Kulig","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A. Hartwich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Hartwich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"P. Szyber","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Szyber","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080072091","display_name":"S. Rudzki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Rudzki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"K. Kolomecki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Kolomecki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023686420","display_name":"Marek Dr\u0105\u017ckiewicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Drazkiewicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079115884","display_name":"M. Gutowska-Jablonska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Gutowska-Jablonska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"W. Majewski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Majewski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"F. Trautinger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Trautinger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036681692","display_name":"R Schandalik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Schandalik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004036178","display_name":"A. Pavars","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Pavars","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097638599","display_name":"V. Lovcinoskis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Lovcinoskis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077152126","display_name":"J\u0101nis Gardovskis","orcid":"https://orcid.org/0000-0001-9656-6209","observed_orcids":["https://orcid.org/0000-0001-9656-6209","https://orcid.org/0000-0002-7817-4268"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Gardovskis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091600898","display_name":"Ilona Hartmane","orcid":"https://orcid.org/0000-0002-5008-9694","observed_orcids":["https://orcid.org/0000-0002-5008-9694","https://orcid.org/0000-0001-9642-9300"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Hartmane","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018511432","display_name":"Edgars Zarembo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Zarembo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041843212","display_name":"B.G. Bezrodny","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. G. Bezrodny","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046009658","display_name":"Olena Datsenko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O. B. Datsenko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010852837","display_name":"Oleksandra Stasyshyn","orcid":"https://orcid.org/0000-0002-8366-5926","observed_orcids":["https://orcid.org/0000-0002-8366-5926"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O. V. Stasyshyn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5097506882","display_name":"V. V. Ganzhyi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. V. Ganzhyi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5027928189"],"corresponding_institution_ids":["https://openalex.org/I130828816","https://openalex.org/I2799390153"],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":15.6446,"has_fulltext":false,"cited_by_count":216,"citation_normalized_percentile":{"value":0.99524171,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"65","issue":"Supplement 4","first_page":"iv53","last_page":"iv65"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11153","display_name":"Streptococcal Infections and Treatments","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceftaroline-fosamil","display_name":"ceftaroline fosamil","score":0.996999979019165},{"id":"https://openalex.org/keywords/complicated-skin-and-skin-structure-infections","display_name":"complicated skin and skin structure infections","score":0.9940000176429749},{"id":"https://openalex.org/keywords/methicillin-resistant-staphylococcus-aureus","display_name":"methicillin-resistant Staphylococcus aureus","score":0.9789999723434448},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.8889999985694885},{"id":"https://openalex.org/keywords/clinical-cure-rate","display_name":"clinical cure rate","score":0.8939999938011169},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.6240000128746033},{"id":"https://openalex.org/keywords/intravenous-antibiotics","display_name":"intravenous antibiotics","score":0.6430000066757202},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7549999952316284},{"id":"https://openalex.org/keywords/gram-positive-pathogens","display_name":"Gram-positive pathogens","score":0.40400001406669617},{"id":"https://openalex.org/keywords/gram-negative-pathogens","display_name":"Gram-negative pathogens","score":0.8759999871253967}],"concepts":[{"id":"https://openalex.org/C2780416669","wikidata":"https://www.wikidata.org/wiki/Q418546","display_name":"Aztreonam","level":5,"score":0.8743702173233032},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8116267919540405},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6920697689056396},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5341500043869019},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.49460098147392273},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4404182732105255},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.44016772508621216},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40611904859542847},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35166844725608826},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3401942253112793},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.30819451808929443},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.20699405670166016},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.20117062330245972},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08247512578964233},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.04513111710548401},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000097583","descriptor_name":"Ceftaroline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001398","descriptor_name":"Aztreonam","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001398","descriptor_name":"Aztreonam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001398","descriptor_name":"Aztreonam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017192","descriptor_name":"Skin Diseases, Bacterial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017192","descriptor_name":"Skin Diseases, Bacterial","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D018461","descriptor_name":"Soft Tissue Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018461","descriptor_name":"Soft Tissue Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D055624","descriptor_name":"Methicillin-Resistant Staphylococcus aureus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/jac/dkq255","doi":"https://doi.org/10.1093/jac/dkq255","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkq255","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:21115455","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21115455","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W992226168","https://openalex.org/W1822917180","https://openalex.org/W1879780134","https://openalex.org/W2010746820","https://openalex.org/W2036153776","https://openalex.org/W2040587302","https://openalex.org/W2076871473","https://openalex.org/W2085878915","https://openalex.org/W2099274786","https://openalex.org/W2103996474","https://openalex.org/W2109128984","https://openalex.org/W2109417549","https://openalex.org/W2110302688","https://openalex.org/W2114585210","https://openalex.org/W2115486016","https://openalex.org/W2115771487","https://openalex.org/W2117699797","https://openalex.org/W2119330671","https://openalex.org/W2119407884","https://openalex.org/W2122909249","https://openalex.org/W2124811643","https://openalex.org/W2126237265","https://openalex.org/W2127077430","https://openalex.org/W2131018144","https://openalex.org/W2131316809","https://openalex.org/W2134902065","https://openalex.org/W2144195043","https://openalex.org/W2151150074","https://openalex.org/W2155864378","https://openalex.org/W2155965882","https://openalex.org/W2156172029","https://openalex.org/W2156888060","https://openalex.org/W2158625612","https://openalex.org/W2168482920"],"related_works":["https://openalex.org/W4237533259","https://openalex.org/W2130945753","https://openalex.org/W2155965882","https://openalex.org/W2516738638","https://openalex.org/W2134902065","https://openalex.org/W2022273448","https://openalex.org/W2314325697","https://openalex.org/W2923164219","https://openalex.org/W2543459268","https://openalex.org/W2386018652"],"abstract_inverted_index":{"OBJECTIVES:":[0],"New":[1],"therapies":[2],"for":[3,55,138,191,265,296,362],"complicated":[4],"skin":[5,7],"and":[6,17,47,102,146,152,173,195,214,241,263,268,275,286,299,316,329,340,345],"structure":[8],"infections":[9],"(cSSSIs)":[10],"are":[11],"needed":[12],"because":[13,288],"of":[14,29,73,84,119,128,133,168,175,234,244,282,289],"significant":[15],"morbidity":[16],"increasing":[18],"antimicrobial":[19],"resistance.":[20],"Methicillin-resistant":[21],"Staphylococcus":[22],"aureus":[23],"(MRSA)":[24],"is":[25],"a":[26,33,58],"common":[27,294,342],"cause":[28],"cSSSIs.":[30,363],"Ceftaroline":[31,273,323],"fosamil,":[32],"novel":[34],"parenteral":[35],"cephalosporin":[36],"with":[37,91,111,351],"excellent":[38],"in":[39,57,79,97,202,231,236,246,256],"vitro":[40],"activity":[41],"against":[42,335],"Gram-positive":[43],"pathogens,":[44,50],"including":[45],"MRSA,":[46],"many":[48],"Gram-negative":[49],"was":[51,67,261,333,346],"evaluated":[52],"as":[53],"therapy":[54,96,115],"cSSSIs":[56,112,228,336],"multinational":[59],"Phase":[60],"III":[61],"study.":[62],"The":[63,162,181,252,292],"primary":[64],"study":[65,163],"objective":[66],"to":[68,88,357],"determine":[69],"non-inferiority":[70],"[lower":[71],"limit":[72],"95%":[74,210,221],"confidence":[75],"interval":[76],"(CI),":[77],"-10%]":[78],"the":[80,98,192,203,237,247,257,355],"clinical":[81,327],"cure":[82,189,328],"rate":[83,255],"ceftaroline":[85,120,171,193,238,266,297,352],"fosamil":[86,121,172,194,239,267,274,298,324,353],"monotherapy":[87],"that":[89],"achieved":[90],"vancomycin":[92,129,178,196,248,269,276,300],"plus":[93,130,179,197,249,270,277,301],"aztreonam":[94,134,198,250,278,302],"combination":[95],"clinically":[99],"evaluable":[100,259],"(CE)":[101],"modified":[103],"intent-to-treat":[104],"(MITT)":[105],"analysis":[106],"populations.":[107],"METHODS:":[108],"Adult":[109],"patients":[110,235,245],"requiring":[113],"intravenous":[114],"received":[116,170,177],"600":[117],"mg":[118],"every":[122,135],"12":[123,136],"h":[124,137],"or":[125],"1":[126,131,142],"g":[127,132],"5-14":[139],"days":[140],"(randomized":[141],":":[143],"1).":[144],"Clinical":[145,188],"microbiological":[147,253,330],"response,":[148],"adverse":[149],"events":[150],"(AEs)":[151],"laboratory":[153],"tests":[154],"were":[155,200,229],"assessed.":[156],"Registration":[157],"number":[158],"NCT00423657":[159],"(http://clinicaltrials.gov/ct2/show/NCT00423657).":[160],"RESULTS:":[161],"enrolled":[164],"694":[165],"patients,":[166],"348":[167],"whom":[169,176],"346":[174],"aztreonam.":[180],"treatment":[182,361],"groups":[183,199],"had":[184,279],"comparable":[185],"baseline":[186],"characteristics.":[187],"rates":[190,281],"similar":[201,280],"CE":[204],"(92.2%,":[205],"271/294":[206],"versus":[207,218,306,310,314,319],"92.1%,":[208],"269/292;":[209],"CI,":[211,222],"-4.4,":[212],"4.5)":[213],"MITT":[215],"(85.1%,":[216],"291/342":[217],"85.5%,":[219],"289/338;":[220],"-5.8,":[223],"5.0)":[224],"populations,":[225],"respectively.":[226,272,321],"MRSA":[227,339],"cured":[230],"91.4%":[232],"(64/70)":[233],"group":[240],"93.3%":[242],"(56/60)":[243],"group.":[251],"success":[254,331],"microbiologically":[258],"population":[260],"92.9%":[262],"95.0%":[264],"aztreonam,":[271],"AEs,":[283],"serious":[284],"AEs":[285,295],"discontinuations":[287],"an":[290,359],"AE.":[291],"most":[293],"included":[303],"diarrhoea":[304],"(6.5%":[305],"4.4%),":[307],"nausea":[308],"(6.2%":[309],"5.6%),":[311],"headache":[312],"(5.3%":[313],"5.3%)":[315],"pruritus":[317],"(3.8%":[318],"8.3%),":[320],"CONCLUSIONS:":[322],"demonstrated":[325],"high":[326],"rates,":[332],"efficacious":[334],"caused":[337],"by":[338],"other":[341],"cSSSI":[343],"pathogens":[344],"generally":[347],"well":[348],"tolerated.":[349],"Monotherapy":[350],"has":[354],"potential":[356],"provide":[358],"alternative":[360]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":19},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":19},{"year":2012,"cited_by_count":32}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}